These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 13488431)

  • 21. Dirithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy.
    Brogden RN; Peters DH
    Drugs; 1994 Oct; 48(4):599-616. PubMed ID: 7528132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of blood levels after oral administration of erythromycin and erythromycin estolate.
    GRIFFITH RS; BLACK HR
    Antibiot Chemother (Northfield); 1962 Jun; 12():398-403. PubMed ID: 13901859
    [No Abstract]   [Full Text] [Related]  

  • 23. [Study of the blood levels obtained with 2 new esters of erythromycin: propionyl erythromycin and propionyl erythromycin lauryl sulfate].
    VIALLIER J; OLLAGNIER C; RONDELET J; AUGAGNEUP J
    Therapie; 1961; 16():878-95. PubMed ID: 13925737
    [No Abstract]   [Full Text] [Related]  

  • 24. International standard for erythromycin.
    HUMPHREY JH; LIGHTBOWN JW; MUSSETT MV
    Bull World Health Organ; 1957; 17(4-5):527-35. PubMed ID: 13511132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COMPARISON OF THE BLOOD LEVELS OBTAINED AFTER SINGLE AND MULTIPLE DOSES OF ERYTHROMYCIN ESTOLATE AND ERYTHROMYCIN STEARATE.
    GRIFFITH RS; BLACK HR
    Am J Med Sci; 1964 Jan; 247():69-74. PubMed ID: 14106882
    [No Abstract]   [Full Text] [Related]  

  • 26. Erythromycin series. IV. Thin-layer chromatography of erythromycin, erythromycin oxime, erythromyclamine and their acyl derivatives.
    Kobrehel G; Tamburasev Z; Djokić S
    J Chromatogr; 1977 Mar; 133(2):415-9. PubMed ID: 838822
    [No Abstract]   [Full Text] [Related]  

  • 27. Drug resistance of staphylococci. Foation of erythromycin-ribosome complex. Decrease in the formation of erythromycin-ribosome complex in erythromycin resistant strains of Staphylococcus aureus.
    Saito T; Hashimoto H; Mitsuhashi S
    Jpn J Microbiol; 1969 Mar; 13(1):119-21. PubMed ID: 5305691
    [No Abstract]   [Full Text] [Related]  

  • 28. [COMPARATIVE EVALUATION OF THE EFFECTIVNESS OF AN ERYTHROMYCIN BASE AND ERYTHROMYCIN ASCORBATE IN EXPERIMENTAL MENINGITIS].
    IMSHENETSKAIA VF
    Antibiotiki; 1963 Jun; 8():533-5. PubMed ID: 14078820
    [No Abstract]   [Full Text] [Related]  

  • 29. UK guidelines for use of erythromycin chemoprophylaxis in persons exposed to pertussis.
    Dodhia H; Crowcroft NS; Bramley JC; Miller E
    J Public Health Med; 2002 Sep; 24(3):200-6. PubMed ID: 12831090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Streptococcal pharyngitis. Evaluation of erythromycin, erythromycin-sulfas, and sulfamethoxazole (possible antagonism between erythromycin and sulfas).
    Hughes WT; Collier RN
    Am J Dis Child; 1969 Nov; 118(5):700-7. PubMed ID: 5348368
    [No Abstract]   [Full Text] [Related]  

  • 31. Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy.
    Peters DH; Friedel HA; McTavish D
    Drugs; 1992 Nov; 44(5):750-99. PubMed ID: 1280567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. QTc-interval prolongation associated with slow intravenous erythromycin lactobionate infusions in critically ill patients: a prospective evaluation and review of the literature.
    Tschida SJ; Guay DR; Straka RJ; Hoey LL; Johanning R; Vance-Bryan K
    Pharmacotherapy; 1996; 16(4):663-74. PubMed ID: 8840374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clarithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential.
    Peters DH; Clissold SP
    Drugs; 1992 Jul; 44(1):117-64. PubMed ID: 1379907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dirithromycin: a new macrolide.
    Wintermeyer SM; Abdel-Rahman SM; Nahata MC
    Ann Pharmacother; 1996 Oct; 30(10):1141-9. PubMed ID: 8893122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A review of erythromycin-induced malignant tachyarrhythmia--torsade de pointes. A case report.
    Katapadi K; Kostandy G; Katapadi M; Hussain KM; Schifter D
    Angiology; 1997 Sep; 48(9):821-6. PubMed ID: 9313632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthetic studies of erythromycin derivatives. Synthesis and antimicrobial activities of 3''-EPI-erythromycin A and (9S)-11-dehydroxy-9-deoxo-9-hydroxy-11- oxoerythromycin A.
    Nakata M; Tamai T; Miura Y; Kinoshita M; Tatsuta K
    J Antibiot (Tokyo); 1993 May; 46(5):813-26. PubMed ID: 8514636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carbamazepine toxicity precipitated by intravenous erythromycin.
    Mitsch RA
    DICP; 1989 Nov; 23(11):878-9. PubMed ID: 2596129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of erythromycin base and erythromycin esters on protein synthesis in vivo in Escherichia coli.
    Andersson SG; Kurland CG
    J Antimicrob Chemother; 1988 Nov; 22(5):605-12. PubMed ID: 3061998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of oral erythromycin for the treatment of gastrointestinal dysmotility in preterm infants.
    Ng PC
    Neonatology; 2009; 95(2):97-104. PubMed ID: 19218823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Erythromycin levels in serum during treatment with erythromycin stearate and base.
    Saarni H; Kanto J; Allonen H
    Ann Clin Res; 1979 Oct; 11(5):196-8. PubMed ID: 397800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.